Performance of Different Mono- and Multiplex Nucleic Acid Amplification Tests on a Multipathogen External Quality Assessment Panel
Open Access
- 1 March 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (3), 977-987
- https://doi.org/10.1128/jcm.00200-11
Abstract
An external quality assessment (EQA) panel consisting of a total of 48 samples in bronchoalveolar lavage (BAL) fluid or transport medium was prepared in collaboration with Quality Control for Molecular Diagnostics (QCMD) ( www.qcmd.org ). The panel was used to assess the proficiency of the three laboratories that would be responsible for examining the 6,000 samples to be collected in the GRACE Network of Excellence ( www.grace-lrti.org ). The main objective was to decide on the best-performing testing approach for the detection of influenza viruses A and B, parainfluenza virus types 1 to 3, respiratory syncytial virus (RSV), human metapneumovirus, coronavirus, rhinovirus, adenovirus, Chlamydophila pneumoniae , Mycoplasma pneumoniae , and Legionella pneumophila by nucleic acid amplification techniques (NAATs). Two approaches were chosen: (i) laboratories testing samples using their in-house procedures for extraction and amplification and (ii) laboratories using their in-house amplification procedures on centrally extracted samples. Furthermore, three commercially available multiplex NAAT tests—the ResPlex (Qiagen GmbH, Hilden, Germany), RespiFinder plus (PathoFinder, Maastricht, The Netherlands), and RespiFinder Smart 21 (PathoFinder) tests—were evaluated by examination of the same EQA panel by the manufacturer. No large differences among the 3 laboratories were noticed when the performances of the assays developed in-house in combination with the in-house extraction procedures were compared. Also, the extraction procedure (central versus local) had little effect on performance. However, large differences in amplification efficacy were found between the commercially available tests; acceptable results were obtained by using the PathoFinder assays.Keywords
This publication has 15 references indexed in Scilit:
- Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in childrenClinical Microbiology & Infection, 2011
- Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the communityJournal of Medical Virology, 2010
- Detection of Respiratory Viruses by Molecular MethodsClinical Microbiology Reviews, 2008
- Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumoniaJournal of Microbiological Methods, 2008
- Acute Respiratory Infection Due to Chlamydia pneumoniae: Current Status of Diagnostic MethodsClinical Infectious Diseases, 2007
- Evaluation of NucliSens easyMAG for Automated Nucleic Acid Extraction from Various Clinical SpecimensJournal of Clinical Microbiology, 2007
- Diagnosis of human metapneumovirus and rhinovirus in patients with respiratory tract infections by an internally controlled multiplex real-time RNA PCRJournal of Clinical Virology, 2005
- Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain ReactionClinical Infectious Diseases, 2005
- Rapid and Sensitive Method Using Multiplex Real-Time PCR for Diagnosis of Infections by Influenza A and Influenza B Viruses, Respiratory Syncytial Virus, and Parainfluenza Viruses 1, 2, 3, and 4Journal of Clinical Microbiology, 2004
- Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition controlJournal of Microbiological Methods, 2003